View by Specialty

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

Ophthalmic Business News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 20, 2024
1 min read
Save

Visiox Pharmaceuticals merges with Ocuvex Therapeutics

Visiox Pharmaceuticals merges with Ocuvex Therapeutics

Visiox Pharmaceuticals has entered into a definitive merger agreement with Ocuvex Therapeutics, according to a press release.

SPONSORED CONTENT
August 19, 2024
4 min read
Save

Key elements to consider when buying equipment for your medical practice

Key elements to consider when buying equipment for your medical practice

As medical technology quickly evolves, practices in nearly all areas of medicine must frequently evaluate equipment upgrades and new purchases of new technology to stay at the forefront of patient care.

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

SPONSORED CONTENT
August 18, 2024
1 min read
Save

FDA roundup: Recent news in ophthalmology

FDA roundup: Recent news in ophthalmology

Healio’s recent FDA news in ophthalmology includes the approval of Enzeevu for neovascular age-related macular degeneration and a rare pediatric disease designation for an X-linked retinoschisis candidate.

SPONSORED CONTENT
August 17, 2024
7 min watch
Save

Jennifer Loh, MD, on taking the leap to start your own practice

Jennifer Loh, MD, on taking the leap to start your own practice

My name is Jennifer Loh, and I'm an ophthalmologist in South Florida, but I did start my own practice about 8 years ago now.

SPONSORED CONTENT
August 15, 2024
1 min read
Save

Gene therapy for X-linked retinoschisis receives rare pediatric disease designation

Gene therapy for X-linked retinoschisis receives rare pediatric disease designation

The FDA granted rare pediatric disease designation to ATSN-201, a gene therapy candidate for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.

SPONSORED CONTENT
August 14, 2024
1 min read
Save

Signal12 readies phase 3 trials for transappendageal forehead delivery of dry eye therapy

Signal12 readies phase 3 trials for transappendageal forehead delivery of dry eye therapy

Spencer Trask & Co. announced the launch of Signal12, a clinical-stage dry eye company that plans to advance Pro-ocular for the treatment of dry eye disease, according to a press release.

SPONSORED CONTENT
August 14, 2024
42 min listen
Save

Friendly but not familiar: Leadership in practice management with Nikie Walker, EdD

Friendly but not familiar: Leadership in practice management with Nikie Walker, EdD

In this episode, Dagny Zhu, MD, and Cathleen McCabe, MD, discuss the unpredictable path of careers, leadership in management and opportunities for growth with Nikie Walker, EdD.

SPONSORED CONTENT
August 13, 2024
1 min read
Save

First patient dosed in phase 2 trial of EC-104 implant for diabetic macular edema

First patient dosed in phase 2 trial of EC-104 implant for diabetic macular edema

Eclipse Life Sciences has enrolled and dosed the first patient in the BETTIS-1 phase 2 clinical trial investigating the EC-104 implant for the treatment of diabetic macular edema, according to a press release.

SPONSORED CONTENT
August 12, 2024
1 min read
Save

FDA approves Enzeevu, aflibercept biosimilar for neovascular AMD

FDA approves Enzeevu, aflibercept biosimilar for neovascular AMD

The FDA approved the Enzeevu 2 mg vial kit and prefilled syringe for intravitreal injection for the treatment of neovascular age-related macular degeneration, according to a press release from Sandoz.

SPONSORED CONTENT
August 12, 2024
2 min read
Save

Tax-advantaged investing: Where to put your next dollar

Tax-advantaged investing: Where to put your next dollar

As your paycheck grows, so does your discretionary spending and saving. While it is easy to spend, it is not always clear where to invest your next dollar intended for future spending.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails